# Long-acting Biomedical HIV Prevention in Transgender Women

> **NCT03856580** · NA · TERMINATED · sponsor: **University of Colorado, Denver** · enrollment: 19 (actual)

## Conditions studied

- HIV Prevention
- Transgender Women

## Interventions

- **BEHAVIORAL:** Alternative long-acting PrEP injection strategies
- **BEHAVIORAL:** mHealth adherence app

## Key facts

- **NCT ID:** NCT03856580
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-10-23
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** New York State Psychiatric Institution-wide research pause affecting all studies
- **Last updated:** 2024-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03856580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03856580, "Long-acting Biomedical HIV Prevention in Transgender Women". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03856580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*